Since it was demonstrated that E2 treatment could enhance the c-Myc expression in ovarian cancer cells [45], inhibition of c-Myc expression through blocking estrogen signaling may also contribute to the suppression of cancer progression. The gene discussed is MYC; the disease is cancer.